4DMedical Ltd ( (AU:4DX) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
4DMedical Ltd’s stock is on the rise following the company’s recent FDA 510(k) submission for its groundbreaking CT:VQ™ software. This innovative technology promises to revolutionize lung imaging by improving ventilation and perfusion assessments without contrast agents, potentially capturing a significant share of the U.S. nuclear VQ scan market. Analysts have maintained a Buy rating with a price target of A$0.70, reflecting optimism about the company’s growth and the transformative potential of its technology. The company’s dedication to transparency, highlighted in a recent investor presentation, further bolsters investor confidence.
More about 4DMedical Ltd
YTD Price Performance: -45.83%
Average Trading Volume: 943,917
Technical Sentiment Signal: Sell
Current Market Cap: A$117.1M
For further insights into 4DX stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue